Skip to main content

Advertisement

Table 1 Biochemical monitoring of six patients that completed both phases of trial indicating median baseline value and median change from baseline

From: A pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study

   Triglycerides (mmol/L) Cholesterol (mmol/L) Uric acid (μmol/L) ALT IU/L CRP mg/L
  Baseline 3.62 4.7 402 38.6 5
WMHMS Median change 0.22 0.29 -41 -9 0
  Baseline 5.12 5.35 364 36.8 11
UCCS Median change -1.57 -0.5 -58 -13 -3
  Normal Range 0.42 - 2.00 3.35 - 6.2 149 - 369 <50 <10
  Statistic (p value) 0.56 0.19 0.84 0.84 0.44
  1. Paired non parametric analyses of the change from baseline for each individual were performed to produce the statistic indicated in bold. (ALT: Alanine transaminase; CRP: C-reactive protein).